Back to Trades
McMinn Rachel
Chief Executive OfficerDirectorCIK 0001606302
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
McMinn Rachel, Chief Executive Officer, Director, accounts for 2 disclosed filings worth $2.8M, all concentrated in Neurogene Inc. (NGNE), active 2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Oct 2 | NGNE Neurogene Inc. | McMinn Rachel | Chief Executive Officer, Director | Exercise | $38.3K |
| Feb 24 | NGNE Neurogene Inc. | McMinn Rachel | Chief Executive Officer, Director | Grant | $2.7M |
2 filings